Charles Schwab’s Merit Medical Systems MMSI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$51.6M Buy
743,937
+68,488
+10% +$4.52M 0.01% 1221
2026
Q1
$46.6M Buy
675,449
+3,227
+0.5% +$252K 0.01% 1214
2025
Q4
$59.2M Buy
672,222
+4,824
+0.7% +$411K 0.01% 1043
2025
Q3
$55.5M Sell
667,398
-30,222
-4% -$2.63M 0.01% 1098
2025
Q2
$65.2M Sell
697,620
-40,035
-5% -$3.79M 0.01% 938
2025
Q1
$78M Sell
737,655
-10,906
-1% -$1.13M 0.01% 784
2024
Q4
$72.4M Buy
748,561
+21,221
+3% +$2.11M 0.01% 850
2024
Q3
$71.9M Buy
727,340
+54,122
+8% +$4.95M 0.01% 855
2024
Q2
$57.9M Buy
673,218
+6,376
+1% +$501K 0.01% 953
2024
Q1
$50.5M Buy
666,842
+14,216
+2% +$1.1M 0.01% 1036
2023
Q4
$49.6M Buy
652,626
+10,659
+2% +$744K 0.01% 983
2023
Q3
$44.3M Buy
641,967
+36,793
+6% +$2.65M 0.01% 961
2023
Q2
$50.6M Buy
605,174
+44,065
+8% +$3.58M 0.01% 853
2023
Q1
$41.5M Buy
561,109
+4,499
+0.8% +$316K 0.01% 962
2022
Q4
$39.3M Buy
556,610
+4,449
+0.8% +$297K 0.01% 968
2022
Q3
$31.2M Buy
552,161
+61,087
+12% +$3.52M 0.01% 1068
2022
Q2
$26.7M Sell
491,074
-1,061
-0.2% -$64.7K 0.01% 1185
2022
Q1
$32.7M Sell
492,135
-10,262
-2% -$617K 0.01% 1166
2021
Q4
$31.3M Buy
502,397
+6,149
+1% +$412K 0.01% 1230
2021
Q3
$35.6M Sell
496,248
-17,513
-3% -$1.19M 0.01% 1096
2021
Q2
$33.2M Buy
513,761
+8,018
+2% +$496K 0.01% 1171
2021
Q1
$30.3M Buy
505,743
+54,766
+12% +$3.14M 0.01% 1182
2020
Q4
$25M Buy
450,977
+59,114
+15% +$3.05M 0.01% 1230
2020
Q3
$17M Sell
391,863
-40,901
-9% -$1.85M 0.01% 1311
2020
Q2
$19.8M Buy
432,764
+6,942
+2% +$280K 0.01% 1183
2020
Q1
$13.3M Buy
425,822
+23,414
+6% +$834K 0.01% 1278
2019
Q4
$12.6M Buy
402,408
+2,626
+0.7% +$75.2K 0.01% 1530
2019
Q3
$12.2M Buy
399,782
+18,177
+5% +$735K 0.01% 1488
2019
Q2
$22.7M Buy
381,605
+28,331
+8% +$1.62M 0.01% 1045
2019
Q1
$21.8M Buy
353,274
+48,394
+16% +$2.75M 0.01% 1053
2018
Q4
$17M Sell
304,880
-8,682
-3% -$516K 0.01% 1101
2018
Q3
$19.3M Buy
313,562
+42,880
+16% +$2.46M 0.01% 1164
2018
Q2
$13.9M Buy
270,682
+1,297
+0.5% +$64.3K 0.01% 1362
2018
Q1
$12.2M Buy
269,385
+15,517
+6% +$703K 0.01% 1354
2017
Q4
$11M Buy
253,868
+17,999
+8% +$755K 0.01% 1412
2017
Q3
$9.99M Buy
235,869
+11,455
+5% +$462K 0.01% 1431
2017
Q2
$8.56M Buy
224,414
+22,718
+11% +$759K 0.01% 1470
2017
Q1
$5.83M Sell
201,696
-10,713
-5% -$300K 0.01% 1665
2016
Q4
$5.63M Sell
212,409
-38,468
-15% -$929K 0.01% 1659
2016
Q3
$6.09M Sell
250,877
-111,755
-31% -$2.58M 0.01% 1519
2016
Q2
$7.19M Buy
362,632
+2,760
+0.8% +$53.1K 0.01% 1309
2016
Q1
$6.66M Buy
359,872
+10,883
+3% +$189K 0.01% 1331
2015
Q4
$6.49M Buy
348,989
+18,712
+6% +$377K 0.01% 1331
2015
Q3
$7.9M Buy
330,277
+55,327
+20% +$1.3M 0.01% 1143
2015
Q2
$5.92M Buy
274,950
+142,640
+108% +$2.9M 0.01% 1443
2015
Q1
$2.55M Buy
132,310
+18,457
+16% +$329K ﹤0.01% 1921
2014
Q4
$1.97M Sell
113,853
-4,118
-3% -$60.9K ﹤0.01% 2023
2014
Q3
$1.4M Buy
117,971
+2,385
+2% +$31.6K ﹤0.01% 2150
2014
Q2
$1.75M Sell
115,586
-7,584
-6% -$105K ﹤0.01% 2046
2014
Q1
$1.76M Buy
123,170
+11,495
+10% +$171K ﹤0.01% 2023
2013
Q4
$1.76M Buy
111,675
+9,410
+9% +$143K ﹤0.01% 1998
2013
Q3
$1.28M Buy
102,265
+1,902
+2% +$24.5K ﹤0.01% 2089
2013
Q2
$1.14M Buy
+100,363
New +$1.08M ﹤0.01% 2080

Other funds holding MMSI

Charles Schwab's MMSI Position: Q2 2026 in Review

Charles Schwab increased its Merit Medical Systems (MMSI) stake by 10% in Q2 2026, buying an estimated $4.52M and bringing the position to 743,937 shares worth $51.6M. The position accounts for 0.01% of the portfolio, ranked #1221.

Charles Schwab first reported a position in MMSI in Q2 2013 and has held it in 53 quarters since. The position peaked at $78M in Q1 2025. 404 funds tracked by Wall St. Rank hold MMSI as of Q2 2026.

  • Charles Schwab held 743,937 shares of Merit Medical Systems worth $51.6M as of Q2 2026.
  • Charles Schwab bought 68,488 Merit Medical Systems shares in Q2 2026, an estimated $4.52M.
  • Merit Medical Systems made up 0.01% of Charles Schwab's portfolio in Q2 2026, its #1221 holding.
  • Charles Schwab first reported a position in Merit Medical Systems in Q2 2013 and has held it in 53 quarters since.
  • Charles Schwab's Merit Medical Systems position peaked at $78M in Q1 2025.
  • 404 funds tracked by Wall St. Rank held Merit Medical Systems as of Q2 2026.

Based on Charles Schwab's 13F filing for Q2 2026, filed 14 Aug 2026.